|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/00 | |
| A61K 39/00 | |||
| C12N 9/24 |
| (11) | Patento numeris | 1786902 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05790917.8 |
| Europos patento paraiškos padavimo data | 2005-07-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-05-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-09-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/025831 |
| Data | 2005-07-21 |
| (87) | Numeris | WO 2006/031291 |
| Data | 2006-03-23 |
| (30) | Numeris | Data | Šalis |
| 939262 | 2004-09-10 | US |
| (72) |
FANG Fang, US
MALAKHOV Michael, US
|
| (73) |
Ansun Biopharma, Inc.,
10665 Sorrento Valley Road, San Diego, California 92121,
US
|
| (54) | A NOVEL CLASS OF THERAPEUTIC PROTEIN BASED MOLECULES |
| A NOVEL CLASS OF THERAPEUTIC PROTEIN BASED MOLECULES |